{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:45:30Z","timestamp":1794707130288,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alanine aminotransferase (ALT) levels are widely used to screen liver disease, and many asymptomatic individuals show elevated ALT levels. As elevated ALT level indicates liver injury, even a small amount of alcohol intake may be harmful in subjects with elevated ALT levels, but there is limited evidence of the effect of light to moderate amount of alcohol intake in this subgroup.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cohort of 367,612 men and women without established liver diseases (including chronic viral hepatitis, alcohol-associated liver disease, cirrhosis, liver transplantation, or rare forms of liver disease) who underwent at least 1 health screening exam between 2009 and 2015 were assessed for liver-related and all-cause mortality. Elevated ALT levels were defined as \u2265 34\u2009U\/L for men and 25\u2009U\/L for women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In participants with normal ALT levels, the fully-adjusted hazard ratios (95% CI) for liver-related mortality comparing light and moderate drinkers to non-drinkers were 0.73 (0.51\u20131.05), and 1.06 (0.73\u20131.52), respectively. In participants with elevated ALT levels, the corresponding hazard ratios were 1.57 (1.08\u20132.28), and 2.09 (CI 1.46\u20132.99), respectively (<jats:italic>p<\/jats:italic> value for alcohol intake by ALT interaction &lt;\u20090.01). For all-cause mortality, the fully-adjusted hazard ratios comparing light and moderate drinkers to non-drinkers in participants with normal ALT levels were 0.72 (0.66\u20130.77), and 0.89 (0.82\u20130.97), respectively. In participants with elevated ALT levels, the corresponding hazard ratios were 0.93 (0.81\u20131.08), and 1.31 (1.14\u20131.50), respectively (<jats:italic>p<\/jats:italic> value for alcohol intake by ALT interaction &lt;\u20090.01).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Small amounts of alcohol intake were associated with increased liver-related and all-cause mortality among individuals with elevated ALT levels. Subjects with elevated ALT levels should be advised complete abstinence from alcohol.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-021-02215-x","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T02:02:26Z","timestamp":1642989746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Dong Hyun","family":"Sinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danbee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Soo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geum-Youn","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"issue":"1","key":"2215_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2017.0112","volume":"24","author":"BH Kim","year":"2018","unstructured":"Kim BH, Park JW. Epidemiology of liver cancer in South Korea. Clin Mol Hepatol. 2018;24(1):1\u20139. https:\/\/doi.org\/10.3350\/cmh.2017.0112.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"2215_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3350\/cmh.2020.0160","volume":"26","author":"SH Park","year":"2020","unstructured":"Park SH, Kim DJ. Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies. Clin Mol Hepatol. 2020;26(4):652\u201361. https:\/\/doi.org\/10.3350\/cmh.2020.0160.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"2215_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.22122\/ahj.v11i2.225","volume":"11","author":"A Iranpour","year":"2019","unstructured":"Iranpour A, Nakhaee N. A Review of Alcohol-Related Harms: A Recent Update. Addict Health. 2019;11(2):129\u201337. https:\/\/doi.org\/10.22122\/ahj.v11i2.225.","journal-title":"Addict Health"},{"issue":"feb22 1","key":"2215_CR4","doi-asserted-by":"publisher","first-page":"d671","DOI":"10.1136\/bmj.d671","volume":"342","author":"PE Ronksley","year":"2011","unstructured":"Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. Bmj. 2011;342(feb22 1):d671. https:\/\/doi.org\/10.1136\/bmj.d671.","journal-title":"Bmj"},{"issue":"3","key":"2215_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.7326\/0003-4819-140-6-200403160-00011","volume":"140","author":"AA Howard","year":"2004","unstructured":"Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med. 2004;140(3):211\u20139. https:\/\/doi.org\/10.7326\/0003-4819-140-6-200403160-00011.","journal-title":"Ann Intern Med"},{"issue":"22","key":"2215_CR6","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1001\/archinte.166.22.2437","volume":"166","author":"A Di Castelnuovo","year":"2006","unstructured":"Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166(22):2437\u201345. https:\/\/doi.org\/10.1001\/archinte.166.22.2437.","journal-title":"Arch Intern Med"},{"issue":"jul10 6","key":"2215_CR7","doi-asserted-by":"publisher","first-page":"g4164","DOI":"10.1136\/bmj.g4164","volume":"349","author":"MV Holmes","year":"2014","unstructured":"Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349(jul10 6):g4164. https:\/\/doi.org\/10.1136\/bmj.g4164.","journal-title":"BMJ"},{"issue":"3","key":"2215_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV, Webber L, et al. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718\u201335. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.011.","journal-title":"J Hepatol"},{"issue":"4","key":"2215_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","volume":"16","author":"AI Cederbaum","year":"2012","unstructured":"Cederbaum AI. Alcohol metabolism. Clin Liver Dis. 2012;16(4):667\u201385. https:\/\/doi.org\/10.1016\/j.cld.2012.08.002.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"2215_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2020;71(1):306\u201333. https:\/\/doi.org\/10.1002\/hep.30866.","journal-title":"Hepatology"},{"issue":"2","key":"2215_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14309\/ajg.0000000000000966","volume":"116","author":"DH Sinn","year":"2021","unstructured":"Sinn DH, Kang D, Guallar E, Chang Y, Ryu S, Zhao D, et al. Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study. Am J Gastroenterol. 2021;116(2):329\u201335. https:\/\/doi.org\/10.14309\/ajg.0000000000000966.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2215_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3350\/cmh.2018.1004","volume":"24","author":"Korean Association for the Study of the Liver","year":"2018","unstructured":"Korean Association for the Study of the Liver. 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C. Clin Mol Hepatol. 2018;24(3):169\u2013229. https:\/\/doi.org\/10.3350\/cmh.2018.1004.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"2215_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3350\/cmh.2019.1002","volume":"25","author":"Korean Association for the Study of the Liver","year":"2019","unstructured":"Korean Association for the Study of the Liver. KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol. 2019;25(2):93\u2013159. https:\/\/doi.org\/10.3350\/cmh.2019.1002.","journal-title":"Clin Mol Hepatol"},{"issue":"13","key":"2215_CR14","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1056\/NEJMra1715733","volume":"379","author":"D Fuster","year":"2018","unstructured":"Fuster D, Samet JH. Alcohol Use in Patients with Chronic Liver Disease. N Engl J Med. 2018;379(13):1251\u201361. https:\/\/doi.org\/10.1056\/NEJMra1715733.","journal-title":"N Engl J Med"},{"issue":"17","key":"2215_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","volume":"342","author":"DS Pratt","year":"2000","unstructured":"Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342(17):1266\u201371. https:\/\/doi.org\/10.1056\/NEJM200004273421707.","journal-title":"N Engl J Med"},{"issue":"1","key":"2215_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","volume":"67","author":"PN Newsome","year":"2018","unstructured":"Newsome PN, Cramb R, Davison SM, Dillon JF, Foulerton M, Godfrey EM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6\u201319. https:\/\/doi.org\/10.1136\/gutjnl-2017-314924.","journal-title":"Gut"},{"issue":"4","key":"2215_CR17","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1053\/gast.2002.36061","volume":"123","author":"RM Green","year":"2002","unstructured":"Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123(4):1367\u201384. S001650850200241X [pii]. https:\/\/doi.org\/10.1053\/gast.2002.36061.","journal-title":"Gastroenterology"},{"issue":"6","key":"2215_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1478-3231.2011.02749.x","volume":"32","author":"HN Park","year":"2012","unstructured":"Park HN, Sinn DH, Gwak GY, Kim JE, Rhee SY, Eo SJ, et al. Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease. Liver Int. 2012;32(6):937\u201344. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02749.x.","journal-title":"Liver Int"},{"issue":"2","key":"2215_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv319","volume":"46","author":"J Lee","year":"2017","unstructured":"Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC). South Korea Int J Epidemiol. 2017;46(2):e15. https:\/\/doi.org\/10.1093\/ije\/dyv319.","journal-title":"South Korea Int J Epidemiol"},{"key":"2215_CR20","volume-title":"National Health Insurance Statistical Yearbook","author":"Health Insurance Review Assessment Service","year":"2010","unstructured":"Health Insurance Review Assessment Service. National Health Insurance Statistical Yearbook. Seoul: National Health Insurance Corporation; 2010."},{"key":"2215_CR21","unstructured":"Chun C-B, Kim S-Y, Lee J-Y, Lee S-Y. Republic of Korea: Health system review. Health Syst Trans. 2009;11(7):1\u2013184."},{"issue":"1","key":"2215_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1001\/jamainternmed.2015.7110","volume":"176","author":"DW Shin","year":"2016","unstructured":"Shin DW, Cho B, Guallar E. Korean National Health Insurance Database. JAMA Intern Med. 2016;176(1):138. https:\/\/doi.org\/10.1001\/jamainternmed.2015.7110.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"2215_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3803\/EnM.2014.29.4.405","volume":"29","author":"MK Kim","year":"2014","unstructured":"Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul). 2014;29(4):405\u20139. https:\/\/doi.org\/10.3803\/EnM.2014.29.4.405.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"5","key":"2215_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"24","key":"2215_CR25","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1002\/sim.2098","volume":"23","author":"AC Thiebaut","year":"2004","unstructured":"Thiebaut AC, Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med. 2004;23(24):3803\u201320. https:\/\/doi.org\/10.1002\/sim.2098.","journal-title":"Stat Med"},{"key":"2215_CR26","volume-title":"Downward Mobility from the Middle Class: Waking Up from the American Dream","author":"G Acs","year":"2011","unstructured":"Acs G. Defining the Middle Class. In: Downward Mobility from the Middle Class: Waking Up from the American Dream; 2011. https:\/\/www.pewtrusts.org\/-\/media\/legacy\/uploadedfiles\/wwwpewtrustsorg\/reports\/economic_mobility\/pewpollprojectfinalsppdf.pdf Accessed 4 Nov, 2021."},{"issue":"3","key":"2215_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cld.2016.02.013","volume":"20","author":"CC Hsu","year":"2016","unstructured":"Hsu CC, Kowdley KV. The Effects of Alcohol on Other Chronic Liver Diseases. Clin Liver Dis. 2016;20(3):581\u201394. https:\/\/doi.org\/10.1016\/j.cld.2016.02.013.","journal-title":"Clin Liver Dis"},{"issue":"3","key":"2215_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/hep.30867","volume":"71","author":"Y Chang","year":"2020","unstructured":"Chang Y, Ryu S, Kim Y, Cho YK, Sung E, Kim HN, et al. Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis. Hepatology. 2020;71(3):861\u201373. https:\/\/doi.org\/10.1002\/hep.30867.","journal-title":"Hepatology"},{"issue":"1","key":"2215_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/hep.30170","volume":"69","author":"Y Chang","year":"2019","unstructured":"Chang Y, Cho YK, Kim Y, Sung E, Ahn J, Jung HS, et al. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study. Hepatology. 2019;69(1):64\u201375. https:\/\/doi.org\/10.1002\/hep.30170.","journal-title":"Hepatology"},{"issue":"3","key":"2215_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/hep.30864","volume":"71","author":"F Aberg","year":"2020","unstructured":"Aberg F, Puukka P, Salomaa V, Mannisto S, Lundqvist A, Valsta L, et al. Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts. Hepatology. 2020;71(3):835\u201348. https:\/\/doi.org\/10.1002\/hep.30864.","journal-title":"Hepatology"},{"issue":"1","key":"2215_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jgh.13857","volume":"33","author":"VW Wong","year":"2018","unstructured":"Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, et al. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol. 2018;33(1):70\u201385. https:\/\/doi.org\/10.1111\/jgh.13857.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"2215_CR32","first-page":"S25","volume":"47","author":"J Rehm","year":"1993","unstructured":"Rehm J, Spuhler T. Measurement error in alcohol consumption: the Swiss Health Survey. Eur J Clin Nutr. 1993;47(Suppl 2):S25\u201330.","journal-title":"Eur J Clin Nutr"},{"issue":"10","key":"2215_CR33","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41395-018-0133-5","volume":"113","author":"T Mitchell","year":"2018","unstructured":"Mitchell T, Jeffrey GP, de Boer B, MacQuillan G, Garas G, Ching H, et al. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. Am J Gastroenterol. 2018;113(10):1484\u201393. https:\/\/doi.org\/10.1038\/s41395-018-0133-5.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2215_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/01.ede.0000112219.01955.56","volume":"15","author":"M Gronbaek","year":"2004","unstructured":"Gronbaek M, Johansen D, Becker U, Hein HO, Schnohr P, Jensen G, et al. Changes in alcohol intake and mortality: a longitudinal population-based study. Epidemiology. 2004;15(2):222\u20138. https:\/\/doi.org\/10.1097\/01.ede.0000112219.01955.56.","journal-title":"Epidemiology"},{"issue":"7","key":"2215_CR35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/aje\/kwr147","volume":"174","author":"WC Kerr","year":"2011","unstructured":"Kerr WC, Greenfield TK, Bond J, Ye Y, Rehm J. Racial and ethnic differences in all-cause mortality risk according to alcohol consumption patterns in the national alcohol surveys. Am J Epidemiol. 2011;174(7):769\u201378. https:\/\/doi.org\/10.1093\/aje\/kwr147.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2215_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/hep.30996","volume":"72","author":"F Stickel","year":"2020","unstructured":"Stickel F, Lutz P, Buch S, Nischalke HD, Silva I, Rausch V, et al. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers. Hepatology. 2020;72(1):88\u2013102. https:\/\/doi.org\/10.1002\/hep.30996.","journal-title":"Hepatology"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02215-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T02:02:32Z","timestamp":1642989752000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02215-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2215"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02215-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"21 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Samsung Medical Center approved the study and waived the requirement for informed consent because NHIS-NSC 2.0 data were publicly available de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}